News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Fischer Laurent
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/17/2023 |
4
| Fischer Laurent (CEO, President and Director) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Sold 41,239 shares
@ $0.7816, valued at
$32.2k
|
|
| 09/21/2022 |
4
| Fischer Laurent (CEO, President and Director) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Sold 41,082 shares
@ $1.0696, valued at
$43.9k
|
|
| 09/16/2022 |
4
| Fischer Laurent (CEO, President and Director) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Granted 675,022 options to buy
@ $1.09, valued at
$735.8k
Granted 584,978 options to buy
@ $1.09, valued at
$637.6k
|
|
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/22/2022 |
4
| Fischer Laurent (CEO, President and Director) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Bought 25,000 shares
@ $1.112, valued at
$27.8k
|
|
| 03/17/2022 |
4
| Fischer Laurent (CEO, President and Director) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Granted 630,000 options to buy
@ $1.29, valued at
$812.7k
|
|
| 03/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2021 |
4
| Fischer Laurent (Director) has filed a Form 4 on Mirum Pharmaceuticals, Inc.|
Txns:
| Granted 17,000 options to buy
@ $16.88, valued at
$287k
|
|
| 03/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/19/2021 |
4
| Fischer Laurent (CEO and Director) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Bought 8,600 shares
@ $11.5338, valued at
$99.2k
|
|
| 08/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2020 |
4
| Fischer Laurent (CEO and Director) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Granted 1,200,000 options to buy
@ $23.7, valued at
$28.4M
|
|
| 06/15/2020 |
4
| Fischer Laurent (Director) has filed a Form 4 on Mirum Pharmaceuticals, Inc.|
Txns:
| Granted 17,000 options to buy
@ $16.71, valued at
$284.1k
|
|
| 03/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/18/2019 |
4
| Fischer Laurent (Director) has filed a Form 4 on Mirum Pharmaceuticals, Inc.|
Txns:
| Bought 452 shares
@ $9.47, valued at
$4.3k
Bought 1,648 shares
@ $9.366, valued at
$15.4k
|
|
| 09/10/2019 |
4
| Fischer Laurent (Director) has filed a Form 4 on Mirum Pharmaceuticals, Inc.|
Txns:
| Bought 1,720 shares
@ $10.7147, valued at
$18.4k
Bought 1,670 shares
@ $10.54, valued at
$17.6k
Bought 300 shares
@ $11.3, valued at
$3.4k
Bought 960 shares
@ $10.2932, valued at
$9.9k
|
|
| 05/20/2019 |
4
| Fischer Laurent (Director) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Granted 120,000 options to buy
@ $0.8411, valued at
$100.9k
|
|
| 05/17/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/25/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/03/2016 |
4
| Fischer Laurent (CEO) has filed a Form 4 on Tobira Therapeutics, Inc.|
Txns:
| Disposed/sold 4,332 options to buy
@ $2.96, valued at
$12.8k
Disposed/sold 4,332 options to buy
@ $3.14, valued at
$13.6k
Disposed/sold 53,616 options to buy
@ $3.14, valued at
$168.4k
Disposed/sold 16,416 options to buy
@ $3.14, valued at
$51.5k
Disposed/sold 83,324 options to buy
@ $4.81, valued at
$400.8k
Disposed/sold 503,882 options to buy
@ $4.81, valued at
$2.4M
Disposed/sold 105,000 options to buy
@ $14, valued at
$1.5M
Disposed/sold 258,000 options to buy
@ $7.91, valued at
$2M
|
|
|
|